Analyses & Studies

Sanofi ready for a Brexit 'no deal' scenario

Sanofi, explains how the company will manage the access to the vaccines and medicines they produce after Brexit.

In a  LinkedIn post, Hugo Fry, Managing Director UK of Sanofi, explains how the company will organise to manage the access to the vaccines and medicines they produce after Brexit.

 

 

Share this page Share on FacebookShare on TwitterShare on Linkedin
Close

JOIN NOW

Become a member and be part of the largest Franco-British business community